Assertio Holdings Inc is projected to rise to $36.40 by 2027, a +55% move from its current price of $23.50. ASRT is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $23.18 | $23.52 | $23.86 | +0.08% |
| Jul 13 | $23.06 | $23.54 | $24.02 | +0.16% |
| Jul 14 | $22.98 | $23.56 | $24.15 | +0.24% |
| Jul 15 | $22.91 | $23.57 | $24.26 | +0.32% |
| Jul 16 | $22.85 | $23.59 | $24.36 | +0.40% |
| Jul 17 | $22.80 | $23.61 | $24.46 | +0.47% |
| Jul 18 | $22.75 | $23.63 | $24.55 | +0.55% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $22.75 | $23.63 | $24.55 | +0.55% |
| Week 2 | $22.52 | $23.76 | $25.07 | +1.11% |
| Week 3 | $22.37 | $23.89 | $25.52 | +1.67% |
| Week 4 | $22.27 | $24.02 | $25.92 | +2.23% |
| Week 5 | $22.19 | $24.16 | $26.30 | +2.80% |
| Week 6 | $22.13 | $24.29 | $26.66 | +3.37% |
| Week 7 | $22.09 | $24.43 | $27.01 | +3.94% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Assertio Holdings, Inc. is a pharmaceutical company that provides various products to patients in the United States. It operates in the healthcare sector and was incorporated in 2020, with headquarters in Lake Forest, Illinois.
Its portfolio includes INDOCIN, Sympazan, CAMBIA, SPRIX, and ROLVEDON, covering treatments for rheumatoid arthritis, seizures, migraine, acute pain, and infection risk from febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020.
These details describe the company’s identity, lineage, and product lineup as a U.S.-focused pharmaceutical provider.
Assertio Holdings, Inc. (ASRT) is a pharmaceutical company with a current price of $23.50 and a market capitalization of $151.86M. It is ranked 3759 by market cap among public companies tracked in this universe.
The current price outlook, as reflected in the near-term forecast, shows an average of $23.50 for 2026 with a neutral sentiment. The longer-range forecast depicts a bullish trajectory, with the average price rising to $59.79 by 2030 (ROI 154.4) and continuing higher to $210.06 by 2040 (ROI 793.9) and $508.43 by 2050 (ROI 2063.5).
Overall, the asset is positioned as a small-cap pharmaceutical with a rising multi-year forecast emphasizing upside potential despite a modest starting point, and a clear progression in average price and ROI through 2030, 2040, and 2050.
A major floor 51.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (0.8% away) — a key level to hold.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 0.5% above — clearing it would confirm fresh momentum.
Key ASRT support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ASRT market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $23.50 | Neutral | $23.50 | Buy |
| MA 10 | $23.50 | Neutral | $23.49 | Buy |
| MA 20 | $23.48 | Buy | $23.34 | Buy |
| MA 50 | $22.11 | Buy | $21.86 | Buy |
| MA 100 | $18.20 | Buy | $19.29 | Buy |
| MA 200 | $14.96 | Buy | $16.61 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 83.59 | Sell |
| Stoch RSI (14) | 66.52 | Neutral |
| CCI (20) | 65.48 | Neutral |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | -0.13 | Sell |
| ROC (12) | 0.09 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.28 | Buy |
| Awesome (5,34) | 0.11 | Buy |
| Ultimate (7,14,28) | 50.00 | Neutral |
| Momentum (10) | 0.02 | Buy |
| Aroon Osc (25) | 100.00 | Buy |
| Hull MA (9) | 23.50 | Sell |
| ADX (14) | 66.20 | Buy |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is bullish, supported by a strong relative strength index and positive momentum indicators.
RSI14 is 80, indicating elevated buying pressure, while the SMA50 sits at $21.56 and the SMA200 at $14.68, signaling a positive trend with a growing longer-term backbone.
Support is at $22.36 and resistance at $23.50, with the 30-day trading range between $21.36 and $25.85. The stock has notable volatility, as shown by its annualized volatility of 30%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.14 | $23.50 | $34.98 | 0% | Neutral | |
| $29.80 | $36.40 | $46.49 | +55% | Bullish | |
| $36.95 | $45.97 | $60.30 | +96% | Bullish | |
| $42.38 | $53.55 | $71.72 | +128% | Bullish | |
| $46.43 | $59.45 | $81.06 | +153% | Bullish | |
| $55.40 | $71.80 | $99.44 | +206% | Bullish | |
| $59.38 | $77.83 | $109.32 | +231% | Bullish | |
| $68.72 | $91.02 | $129.50 | +287% | Bullish | |
| $90.73 | $121.37 | $174.75 | +416% | Bullish | |
| $99.06 | $133.76 | $194.74 | +469% | Bullish | |
| $150.00 | $211.25 | $322.28 | +799% | Bullish | |
| $344.81 | $520.80 | $851.62 | +21.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $9.14 | $23.50 | $28.96 | +0.00% |
| August 2026 | $21.43 | $25.11 | $30.08 | +6.87% |
| September 2026 | $21.45 | $25.25 | $30.47 | +0.55% |
| October 2026 | $22.27 | $26.31 | $31.96 | +4.21% |
| November 2026 | $23.50 | $27.86 | $34.02 | +5.88% |
| December 2026 | $23.96 | $28.50 | $34.98 | +2.31% |
Click any year to see its month-by-month ASRT forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ASRT price prediction for 2026 points to an average of $23.50 (low $9.14, high $34.98) — a potential gain of 0% on today's $23.50. A consolidation phase looks the most probable path here.
In 2027, ASRT is projected to trade between $29.80 and $46.49, averaging $36.40 — a potential gain of +55% from today's $23.50. That is up +55% on the projected 2026 average. Momentum favours further upside here.
Assertio Holdings Inc's 2028 outlook centres on $45.97, within a $36.95 to $60.30 range. That is up +26% on the projected 2027 average. That marks a +96% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, ASRT could reach as high as $71.72, with a base case around $53.55 and support toward $42.38 — roughly +128% from $23.50. Momentum favours further upside here.
Expect ASRT to range from $46.43 to $81.06 through 2030. The $59.45 average target implies a +153% move from current prices. That is up +11% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The ASRT price prediction for 2031 points to an average of $71.80 (low $55.40, high $99.44) — a potential gain of +206% on today's $23.50. Momentum favours further upside here.
In 2032, ASRT is projected to trade between $59.38 and $109.32, averaging $77.83 — a potential gain of +231% from today's $23.50. That is up +8% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Assertio Holdings Inc's 2033 outlook centres on $91.02, within a $68.72 to $129.50 range. That is up +17% on the projected 2032 average. That marks a +287% change versus current levels. Momentum favours further upside here.
By 2034, ASRT could reach as high as $174.75, with a base case around $121.37 and support toward $90.73 — roughly +416% from $23.50. Buyers look set to stay in control over this stretch.
Expect ASRT to range from $99.06 to $194.74 through 2035. The $133.76 average target implies a +469% move from current prices. That is up +10% on the projected 2034 average. Momentum favours further upside here.
The ASRT price prediction for 2040 points to an average of $211.25 (low $150.00, high $322.28) — a potential gain of +799% on today's $23.50. Buyers look set to stay in control over this stretch.
In 2050, ASRT is projected to trade between $344.81 and $851.62, averaging $520.80 — a potential gain of +21.2x from today's $23.50. That is up +147% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in ASRT today (≈ 42.553191 ASRT) could be worth
$22,161.51
+$21,161.51 (+2116%) by 2050 · US Dollar
Based on the average projected ASRT price of $520.8 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ASRTwould be worth at today's price.
$1,000 invested in ASRT on Jun 30, 2025 (≈ 104.166663 ASRT) would be worth
$2,447.92
+$1,447.92 (+144.8%) today · 2.45× · US Dollar
Based on a ASRT entry price of $9.6 vs. today's $23.5.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $23.5 | $1,000 | +0.0% |
| 1 month ago | $23.44 | $1,002.56 | +0.3% |
| 3 months ago | $19.06 | $1,232.95 | +23.3% |
| 6 months ago | $9.07 | $2,590.96 | +159.1% |
| 1 year ago | $9.6 | $2,447.92 | +144.8% |
| All time (5.0y) ago | $21 | $1,119.05 | +11.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ASRT forecast.
Our base-case forecast reaches $47.00 around 2029.
Implied market cap at $47.00: $303.72M
The multi-year forecast paints a bullish path for Assertio, with strong upside potential over time. In 2030, the average forecast price is $59.79 and the ROI is 154.4, with a bullish sentiment. The 2040 forecast shows an average of $210.06 and a ROI of 793.9, continuing the bullish trajectory.
By 2050, the average is $508.43 with a ROI of 2063.5, underscoring a long-term growth expectation.
These projections imply substantial upside from today’s levels, tempered by the inherent uncertainty of long-horizon forecasts.
Tap a question to reveal the answer.
2030: Avg $59.79, Min $46.67, Max $81.57, ROI 154.4, Sentiment BULLISH.
Forecasts show bullish sentiment in 2030 and beyond, with rising average prices (2030: $59.79) and higher ROIs (e.g., 154.4 by 2030, 2063.5 by 2050). Use caution, as these are estimates and not guarantees.
Yes. The forecast shows 2032 Max $107.69 and 2033 Max $130.87, indicating the possibility of exceeding $100 within the forecast window.
Current price is $23.50 and market cap is $151.86M, with a rank of 3759.
Bullish sentiment with RSI14 at 80, SMA50 at $21.56, SMA200 at $14.68. Support is at $22.36, resistance at $23.50, and the 30-day range is $21.36 to $25.85.
Assertio Holdings Inc Community Discussion
0Share your Assertio Holdings Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.